Food and beverage trends are going head-to-head, as different attitudes to eating styles compete for supremacy. So, which ...

There has been a lot of conversation lately about if new weight loss drugs like Wegovy and Mounjaro should be covered by ...

Takers of GLP-1 are reportedly going on a "holiday pause" to enjoy meal centric family celebrations. Here, an MD breaks down ...

Music star Lizzo credits three healthy habits with helping her lose over 60 pounds without taking a GLP-1 drug like Ozempic.

On Tuesday, the Biden administration proposed a new policy that would allow Medicare and Medicaid to cover weight loss drugs ...

Ozempic, a weight loss medication, can lead to both positive and negative mood changes. Learn how it affects personality and ...

The CMS estimated that coverage of the weight-loss drugs will cost the federal government about $25 billion for Medicare and ...

A new weight loss drug called MariTide caused 20 percent weight loss in a recent trial, even better than Wegovy or Ozempic.

Berberine, green tea extract and taurine are just some of the ingredients advertised as being able to ‘boost’ GLP-1 levels.

Amgen's MariTide shows promising weight loss results in Phase II for type 2 diabetes. Find out why AMGN stock remains as a strong buy for long-term investors.

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

Mounjaro is a treatment for Type 2 diabetes that activates GIP and GLP-1 pathways to help regulate blood sugar. It’s part of ...